| Drug Name: | Erlotinib (183321-74-6) |
|---|---|
| PubChem ID: | 176870 |
| SMILES: | COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC |
| InchiKey: | AAKJLRGGTJKAMG-UHFFFAOYSA-N |
| Therapeutic Category: | Enzyme Inhibitors, Protein Kinase Inhibitors |
| Molecular Weight (dalton) | : | 393.443 |
| LogP | : | 3.4051 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 7 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 74.73 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|---|---|
| Grapefruit Juice | Bone Marrow Toxicity | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
| Grapefruit Juice | Torsade De Pointes | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category